Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, posted on X:
“Happened to raise some critical points regarding the “final overall survival results of checkmate 067” in today’s edition of NEJM.
Happy that the authors have responded.”
